XPO1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.567000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.244200E-01
Normal-vs-Stage2
2.215400E-01
Normal-vs-Stage3
2.020800E-01
Normal-vs-Stage4
7.848000E-01
Stage1-vs-Stage2
3.943600E-02
Stage1-vs-Stage3
4.020600E-01
Stage1-vs-Stage4
2.124400E-01
Stage2-vs-Stage3
6.996100E-02
Stage2-vs-Stage4
4.136400E-01
Stage3-vs-Stage4
1.157200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.669400E-01
Normal-vs-AfricanAmerican
3.756400E-01
Normal-vs-Asian
2.343200E-01
Caucasian-vs-AfricanAmerican
7.040200E-01
Caucasian-vs-Asian
5.962000E-01
AfricanAmerican-vs-Asian
9.904800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.042600E-01
Normal-vs-Female
5.550000E-01
Male-vs-Female
9.124800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.515600E-01
Normal-vs-Age(41-60Yrs)
7.016400E-01
Normal-vs-Age(61-80Yrs)
1.461800E-01
Normal-vs-Age(81-100Yrs)
5.648200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.144800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.590800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.360400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.702400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.775800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.311400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.020600E-01
Normal-vs-Daily Drinker
2.081200E-01
Normal-vs-Weekly Drinker
4.529600E-01
Normal-vs-Occasional Drinker
7.785200E-01
Normal-vs-Social Drinker
6.517200E-01
Non Drinker-vs-Daily Drinker
8.095400E-01
Non Drinker-vs-Weekly Drinker
8.247600E-01
Non Drinker-vs-Occasional Drinker
2.918400E-02
Non Drinker-vs-Social Drinker
2.720000E-01
Daily Drinker-vs-Weekly Drinker
6.414400E-01
Daily Drinker-vs-Occasional Drinker
6.502000E-02
Daily Drinker-vs-Social Drinker
3.483400E-01
Weekly Drinker-vs-Occasional Drinker
1.685860E-02
Weekly Drinker-vs-Social Drinker
1.558160E-01
Occasional Drinker-vs-Social Drinker
3.833200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.611800E-01
Normal-vs-Grade 2
5.784000E-01
Normal-vs-Grade 3
5.228200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.060820E-01
Grade 1-vs-Grade 3
1.095820E-02
Grade 1-vs-Grade 4
6.611800E-01
Grade 2-vs-Grade 3
7.643800E-02
Grade 2-vs-Grade 4
5.784000E-01
Grade 3-vs-Grade 4
5.228200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.413800E-01
Normal-vs-NonDiabetic
5.718400E-01
Diabetic-vs-NonDiabetic
7.353700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.368600E-01
Normal-vs-NoPancreatitis
5.202200E-01
Pancreatitis-vs-NoPancreatitis
1.917760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.253400E-01
Normal-vs-N1
2.374200E-01
N0-vs-N1
4.478200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.069800E-01
Normal-vs-TP53-NonMutant
4.749800E-01
TP53-Mutant-vs-TP53-NonMutant
1.83521999999048E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
